baber/WOPTO huggingface dataset:
Patent DE-69529920-T2 (DE)
Inventor: CHIRNSIDE EWAN DOUGLAS
IPC: A61P31/12
Filed: 1995-01-13
Granted: 2004-01-15
Abstract: PCT No. PCT/GB95/00066 Sec. 371 Date Jul. 31, 1996 Sec. 102(e) Date Jul. 31, 1996 PCT Filed Jan. 13, 1995 PCT Pub. No. WO95/19438 PCT Pub. Date Jul. 20, 1995This invention provides a peptide or peptide conjugate of the equine arteritis virus GL protein which elicits an immune response in animals to whom the peptide or peptide conjugate is administered and results in the production of neutralizing antibodies against equine arteritis virus, the peptide or peptide conjugate corresponds to amino acid sequences of SEQ ID NOs:3, 4, 5, 6 and 7.
Patent DE-69530816-T2 (DE)
Inventor: SUDA ARUNA ROHRA
IPC: G06F17/24
Filed: 1995-06-21
Granted: 2004-04-08
Abstract: System and method for preparing a text by using a knowledge base, by which knowledge relating to input information is first retrieved from the knowledge base. Then, a plurality of kinds of information used as elements of a text to be generated is selected from the input information and the retrieved information relating thereto. Subsequently, a describing order, in which the selected elements of the text are described, is determined. Then, a text to be outputted is generated on the basis of the selected elements of the text, the describing order of which has been determined. Thereby, a text, whose contents and structure meet a user's purpose, is generated from the input simple information. <MATH>
Patent DE-69530890-T2 (DE)
Inventor: SMALL EDWARD CHARLES
IPC: D21H27/02
Filed: 1995-04-27
Granted: 2003-12-24
Abstract: Speckle-patterned paper is produced on the paper machine without the use of printing techniques by first preparing speckle-forming material and then introducing this into a contrasting colour papermaking furnish. Paper is then made from the speckle-containing furnish in the normal way. The speckle-forming material is produced by dry comminution of cellulose fibre aggregates in the form of paper or entangled fibre clumps.
Patent DE-69530933-T2 (DE)
Inventor: FRIEDMAN EITAN
IPC: A61P25/28
Filed: 1995-10-24
Granted: 2004-02-12
Abstract: Use of the novel receptor NER TOFA (5-(tetradecyloxy)-2-furan-carboxylic acid) to treat Alzheimer's disease.
Patent DE-69532390-T2 (DE)
Inventor: SEARE WILLIAM J
IPC: A61L27/00
Filed: 1995-10-25
Granted: 2004-11-11
Abstract: A porous implant and method of making such is disclosed. A mold form material (164) is created by adhering solid particles together to form a porous network. A liquid phase of a final product is forced through the interstices of the mold form (164), and then most of the liquid material is forced out of the interstices leaving a thin coat (162). Next, the thin coat is cured to produce a thin coat of a polymer such as silicone rubber (162). Next, the mold form material (164) is dissolved out creating a porous structure containing only the cured polymer.
Patent DE-69532965-T2 (DE)
Inventor: FLANAGAN J
IPC: C07D285/00
Filed: 1995-10-11
Granted: 2005-06-09
Abstract: Novel N3S2 chelating ligands can be chelated to a radiodetectable element, Tc or Re, and are useful for radiolabeling peptides. A group of peptides especially useful are somatostatin derivatives which are valuable of the selective detection or treatment of tumors with somatostatin receptors.
Patent DE-69600356-T2 (DE)
Inventor: AUSTIN ANNE-MARIE B
IPC: C09K23/00
Filed: 1996-02-14
Granted: 1999-02-25
Abstract: Water soluble polymers are prepared from an allyloxybenzenesulfonic acid monomer, a methallyl sulfonic acid monomer, a copolymerizable nonionic monomer, and a copolymerizable olefinically unsaturated carboxylic acid monomer. The polymers are used to disperse particulate matter and to inhibit the formation and deposition of mineral scale in aqueous systems and are used in detergent compositions.
Patent DE-69606651-T2 (DE)
Inventor: SHINITZKY MEIR
IPC: G01N33/569
Filed: 1996-09-26
Granted: 2000-06-15
Abstract: An assay for the diagnosis of multi-infarct dementia and dementia of the Alzheimer type in an individual is provided. It comprises the steps of obtaining a sample from said individual being a blood sample, a platelet-containing fragment thereof, or a fragment containing platelet associated antibodies (PAA) detached from the platelets, and then determining the level of a platelet associated antibody against a 75 kD platelet-protein in said sample. A level higher than that of a control sample indicates that said individual has a high likelihood of having multi-infarct dementia or dementia of the Alzheimer type.
Patent DE-69622429-T2 (DE)
Inventor: WITHERS G
IPC: C07K19/00
Filed: 1996-12-12
Granted: 2002-11-28
Abstract: Mutant glycosidase enzymes are formed in which the normal nucleophilic amino acid within the active site has been changed to a non-nucleophilic amino acid. These enzymes cannot hydrolyze disaccharide products, but can still form them. Using this enzyme, oligoeaccharides are synthesized by preparing a mixture of an  alpha -glycosol fluoride and a glycoside acceptor molecule; enzymatically coupling the  alpha -glycosol fluoride to the glycoside acceptor molecule to form a glycosol glycoside product using the mutant glycosidase enzyme; and recovering the glycosyl product. The enzymes to be used are mutant forms of human or porcine  alpha -amylase or yeast  alpha -glucosidose having two catalytically active amino acids with carboxylic acid side claims within the active site, in the wild-type enzyme, with one of these amino acids being replaced by a different amino acid.
Patent DE-69624222-T2 (DE)
Inventor: LOEHMAR KARL
IPC: A23F5/36
Filed: 1996-02-06
Granted: 2003-07-10
Abstract: PCT No. PCT/IB96/00088 Sec. 371 Date Aug. 6, 1997 Sec. 102(e) Date Aug. 6, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24255 PCT Pub. Date Aug. 15, 1996A soluble coffee is prepared from ground green coffee which is extracted with water, the green extract obtained is dried and green powder obtained by drying is passed into and through a twin-screw extruder, and while the powder is passed through the extruder, the powder is heated in the extruder at a temperature of from 130 DEG  C. to 240 DEG  C. for up to 5 minutes to obtain a heat-caramelized extrudate product from the extruder, and that product is cooled and thereafter dried and ground to provide a powder-form product. Additionally, obtaining green extracts from low temperature and high temperature split extraction enables separate processing of low and high temperature extracted extracts, and low temperature extracted extracts may be heated in an extruder at a temperature of from 180 DEG  C. to 240 DEG  C. and high temperature extracted extracts may be heated in an extruder at a temperature of from 130 DEG  C. to 180 DEG  C. which enables obtaining a balanced product. Further, in the context of use of low and high temperature extraction, an extract may be obtained from roast and ground coffee by low temperature extraction and then the spent grounds and green coffee may be extracted by high temperature extraction, and the extracts may be treated as set forth above.
Patent DE-69631490-T2 (DE)
Inventor: VACANTI A
IPC: C12N5/00
Filed: 1996-11-08
Granted: 2004-10-07
Abstract: The invention provides compositions and methods for generating new tissue on a surface, e.g., a surface of damaged or lost tissue, of a structure or organ in a mammal, The methods involve applying a thin layer of a liquid hydrogel-cell composition to the surface; and allowing the liquid hydrogel-cell composition to solidify, thereby forming a matrix that enables the tissue precursor cells to grow and generate new tissue. The surface can be internal, e.g., the surface of an organ or the internal surface of a blood vessel, or external, e.g., skin.
Patent DE-69633374-T2 (DE)
Inventor: ANDRUS WINFIELD SCOTT
IPC: A61B17/22
Filed: 1996-11-11
Granted: 2005-11-17
Abstract: An apparatus and method for the treatment of diseases of the prostate, including BPH and prostate cancer, utilizing transurethrally applied focussed ultrasound energy to produce hyperthermal and thermotherapeutic effects in diseased tissue are disclosed. A first preferred embodiment of the apparatus relies on visual control; and a second preferred embodiment of the apparatus incorporates an integrated ultrasonic imaging and therapy transducer. The apparatus and method feature the close proximal placement of the ultrasound transducer to the diseased tissue to be treated, resulting in less attenuation of the beam and deposition of a greater fraction of the total emitted ultrasound energy in the selected portion of the diseased tissue. The ultrasound energy passes atraumatically through the urethral wall and other tissue not targeted. At the focal point of the ultrasound energy, substantial heating of diseased tissue to produce hyperthermal effects therein occurs, and even higher thermotherapeutic temperatures are attainable to produce coagulative necrosis of diseased tissue. <IMAGE>
Patent DE-69701381-T2 (DE)
Inventor: BAJUSZ SANDOR
IPC: C07D207/16
Filed: 1997-06-05
Granted: 2000-11-16
Abstract: PCT No. PCT/HU97/00027 Sec. 371 Date Apr. 2, 1999 Sec. 102(e) Date Apr. 2, 1999 PCT Filed Jun. 5, 1997 PCT Pub. No. WO97/46523 PCT Pub. Date Dec. 11, 1997This invention relates to peptide aldehyde derivatives of formula (I): D-Xaa-Pro-Arg-H, wherein Xaa represent a 2-cycloheptyl-2-hydroxyacetyl or 2-cyclopentyl-2-hydroxyacetyl group, Pro represents an L-prolyl residue and Arg represents an L-arginyl residue, their acid-additon salts formed with an organic or inorganic acid and pharmaceutical compositions containing the same. The compounds of formula (I) of the invention have therapeutic, particularly anticoagulant, antiplatelet and antithrombotic properties.
Patent DE-69719763-T2 (DE)
Inventor: OH JAE SEUNG
IPC: C08F4/64
Filed: 1997-08-04
Granted: 2004-02-05
Abstract: An olefinic polymer having improved molecular weight distribution and bulk density is prepared by polymerizing an olefinic monomer and, optionally, a comonomer in the presence of a supported catalyst comprising a modified metallocene and an alkylaluminoxane supported on a carrier in an aliphatic hydrocarbon solvent, the modified metallocene being derived from a metallocene of formula(I) by introducing at least one C5-20 alkyl substituent into a pi-ligand, C1-4 alkylene bridge or silicon bridge thereof and the alkylaluminoxane having a repeating unit of formula(II):wherein:M is Ti, Zr or Hf;X is a halogen, or a C1-3 alkyl group;L1 and L2 are each a pi-ligand selected from the group consisting of cyclopentadienyl, indenyl, fluorenyl and derivatives thereof, and are optionally linked together by a C1-4 alkylene bridge or by a silicon bridge;m is an integer of 2 or more; andR1 is a C1-20 alkyl group.
Patent DE-69723082-T2 (DE)
Inventor: BRON DAN
IPC: A61M5/168
Filed: 1997-07-23
Granted: 2004-04-01
Abstract: PCT No. PCT/IL97/00250 Sec. 371 Date Mar. 18, 1999 Sec. 102(e) Date Mar. 18, 1999 PCT Filed Jul. 23, 1997 PCT Pub. No. WO98/03216 PCT Pub. Date Jan. 29, 1998There is provided a liquid flow regulator, having a split housing (2) including an upper portion (4) connectable to a source of liquid to be dispensed, the upper portion having an inlet port (10) and a lower portion engaging the upper portion and having a control output port leading to the consumer of the liquid, an elastically deformable diaphragm (32) disposed in the housing (2) and defining with a bottom surface of the upper housing portion a first chamber (34), and with a bottom surface of the lower housing portion in which the output control port (24) is made, an output control chamber (36), and a tubular flow attenuator (42) disposed in the housing (2), forming a liquid flow path between the first chamber (34) and the control chamber (36), characterized in that the thickness of the diaphragm (32) is at least equal to the distance between the diaphragm (32) in its state of rest and the output control port (24).
Patent DE-69731657-T2 (DE)
Inventor: BAKER RAYMOND
IPC: A61K31/4015
Filed: 1997-11-25
Granted: 2005-12-01
Abstract: The present invention provides a method for the treatment or prevention of substance use disorders using an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such a NK-1 receptor antagonist.
Patent DE-69732229-T2 (DE)
Inventor: GIANOTTI MARC
IPC: A61F2/00
Filed: 1997-07-17
Granted: 2005-12-29
Abstract: A prosthetic stent with a tubular wall (1) having local inwardly or outwardly formed elevations (7) is presented. Stents having such elevations (7) have a higher mechanical stability if bend according to the curvature of the body vessels to be supported or repaired. Also a method for manufacturing a stent with such elevations (7) is described. <IMAGE>
Patent DE-69737861-T2 (DE)
Inventor: VALET ANDREAS
IPC: C09D4/02
Filed: 1997-06-20
Granted: 2008-02-28
Abstract: By of means of a curing process combining thermal and UV curing it is possible, using compositons comprising (A) a coating system based on a polyacrylate polyol or polyester polyol with melamine, or a polyacrylate polyol and/or polyester with a blocked or unblocked polyisocyanate, or a carboxyl-, anhydride- or amino-functional polyester and/or polyacrylate with an epoxy-functional polyester or polyacrylate, (B) an OH, NH2-,COOH-, Epoxy- or NCO-functional resin containing, in addition, at least one ethylenically unsaturated double bond, which is separated from the functional group by a spacer group, and (C)at least one photoinitiator, to obtain coatings having good surface properties.
Patent DE-69800684-T2 (DE)
Inventor: HOWLETT JR
IPC: B65D81/07
Filed: 1998-07-15
Granted: 2001-08-16
Abstract: An inflatable dunnage bag comprises a first inflatable inner bag (120) comprising an inflatable bladder (123) surrounded by a pair of paper plies (121,122), and a second outer bag (110) comprising two sets of paper plies (140) disposed upon opposite sides of the first inner bag (120). The two sets of paper plies (140) comprising the second outer bag are longitudinally offset with respect to each other so as to form flap members (130) on first ends of each set of paper plies (140) which overhang respective second ends of the opposite set of paper plies. The flap members (130) are respectively folded over the second ends of the opposite set of paper plies (140) as single entities and secured thereto by predetermined hot melt adhesive and cold glue bead patterns (153) and optimally tape (154). The dunnage bag is thus particularly adaptable to being fabricated by automated equipment. <IMAGE>
Patent DE-69802863-T2 (DE)
Inventor: GHOSH ASHIM KUMAR
IPC: B01J29/08
Filed: 1998-05-19
Granted: 2002-07-25
Abstract: Process for the production of ethylbenzene by alkylation over a silicalite alkylation catalyst with the subsequent transalkylation of diethylbenzene with the alkylation catalyst and conditions selected to retard xylene production and also heavies production. A feedstock containing benzene and ethylene is applied to a multi-stage alkylation reaction zone having a plurality of series-connected catalyst beds containing a pentasil molecular sieve alkylation catalyst which is silicalite of a predominantly monoclinic symmetry having a silica/alumina ratio of at least 275. The feedstock is supplied to the alkylation reaction zone to cause gas-phase ethylation of benzene at a flow rate to provide a space velocity of benzene over the catalyst to produce a xylene concentration in the product of about 600 ppm or less based upon the ethylbenzene content. Periodically the space velocity may be increased to a value which is greater than the space velocity associated with a minimum concentration of diethylbenzene in the alkylation product such that diethylbenzene production is enhanced while minimizing any attendant transalkylation reactions within the alkylation reaction zone. This is accompanied by a relatively low xylene content in the product, specifically no more than 600 ppm based upon the ethylbenzene in the product. The output from the alkylation reactor is applied to an intermediate recovery zone for the separation and recovery of ethylbenzene with the recovery of a polyalkylated aromatic component which is supplied along with benzene to a transalkylation reaction zone where the polyalkylated aromatic fraction is subject to disproportionation to provide a reduced diethylbenzene content and an enhanced ethylbenzene content. A specific monoclinic silicalite alkylation catalyst has a silica/alumina ratio of at least 300 and has a crystal size of less than one micron.
Patent DE-69805560-T2 (DE)
Inventor: BIQUEZ FRANCOIS
IPC: H02B13/035
Filed: 1998-02-19
Granted: 2002-12-19
Abstract: The switch has several positions for separating or connecting together an assembly of generator (1), mains transformer (4) and a starter (8). It comprises a generator disconnecting switch (2) and a bar separator (3) for separating or connecting together the generator and the mains transformer, and a starting separator (9) for separating or connecting together the generator and starter. The bar separator comprise a first fixed contact (10) and a first mobile contact (11) co-operating by sliding over the first fixed contact. These two contacts are integrated within the generator disconnecting switch. The starter separator comprises a second fixed contact (13) and a second mobile contact (14) co-operating by rotation with the second fixed contact.
Patent DE-69812575-T2 (DE)
Inventor: VILATO PABLO
IPC: C03C10/00
Filed: 1998-07-29
Granted: 2003-12-24
Abstract: A glass-ceramic plate based on silicon, aluminum and lithium oxides is intended, in particular, to cover heating elements. The plate has a diffuse transmission factor of at least 50%. A process for manufacturing the plate is provided.
Patent DE-69814115-T2 (DE)
Inventor: CHIU HSIN-LIANG
IPC: G06F1/16
Filed: 1998-12-30
Granted: 2003-10-23
Abstract: The present invention relates to a display base which can adjust the angle of the display, especially the angle of a touch screen liquid crystal display of a cash register. The display base mainly comprises an upper body, a lower body and moving means. The upper body is used for mounting a display screen; one side of the upper body is of an arcuate shape. The lower body is used for mounting a calculator device; one side of the lower body is also of an arcuate shape for being connected with the upper body. The moving means is mounted in the upper body, and comprises a motor which can rotate to drive a worm, a worm wheel and a gear engaged with a tooth hole provided on the lower body in order to move the upper body upward and downward to achieve the function of angle adjustment, and the angle displacement of the screen caused by the pressing of the screen will not occur. <IMAGE>
Patent DE-69822825-T2 (DE)
Inventor: ROBRECHTS JOZEF
IPC: G07F7/00
Filed: 1998-06-16
Granted: 2005-01-13
Abstract: The invention is relating to a distributing equipment for piece goods comprising (a) an order device (1), (b) locations (3) where the available piece goods can be arranged in such a way that the same goods are contained at the same location (3), (c) transporting means including a robot (4) cooperating with said order device (1) for moving a specific piece good from the corresponding location (3) to a delivery window (6), (d) a distinctive mark (9) at each of said locations (3) which can be detected by a sensor (10) incorporated in the robot (4), the latter comprising a memory unit cooperating with said sensor (10) for storing the coordinates of said different marks (9), and control means for moving the robot (4) to a location (3) with a mark (9), identified by specific coordinates selected among the stored coordinates. <IMAGE>
Patent DE-69824613-T2 (DE)
Inventor: GIMENEZ DE LOS GALANES M
IPC: G10L21/003
Filed: 1998-01-27
Granted: 2005-07-14
Abstract: A prosody modification system and methodology calculates synchronization marks in an original, quasi-periodic signal to a finer precision than the sampling rate of the original signal. Synthetic synchronization marks are generated according to the desired prosody modification also to a finer precision than the sampling rate of the original signal. Waveforms are extracted from the original signal and are fine-shifted to the exact location on the synthetic time axis by a resampling technique. The fine-shifted waveforms are windowed by an asymmetric filtering window, overlapped, and summed together to produce a synthetic signal.
Patent DE-69827956-T2 (DE)
Inventor: LLINAS-BRUNET MONTSE
IPC: A61K38/21
Filed: 1998-08-10
Granted: 2005-04-14
Abstract: Compound of formula (I) active against the Hepatitis C virus: wherein B is an acyl derivative; a is 0 or 1; R6, when present, is carboxy(lower)alkyl; b is 0 or 1; R5, when present, is C1-6 alkyl, or carboxy (lower)alkyl; Y is H or C1-6 alkyl; R4 is C1-10 alkyl; R3 is C1-10 alkyl; W is -NH-CH(R2)-C(O)-, wherein R2 is C1-6 alkyl; C6 or C10 aryl; C7-16 aralkyl; or carboxy (lower)alkyl; or W is a proline derivative; Q is a group of the formula -Z(R1)-C(O)-R13, wherein Z is CH or N; R1 is C1-6 alkyl or C1-6 alkenyl both optionally substituted with thio or halo,; and R13 is an activated carbonyl substituent, or Q is a phosphonate group of the formula -CH(R1)-P(O)R15R16 wherein R15 and R16 are independently C6-20 aryloxy; and R1 is as defined above.
Patent DE-69830049-T2 (DE)
Inventor: FLETCHER CLARISSA
IPC: A61K8/00
Filed: 1998-03-10
Granted: 2006-01-19
Abstract: The application relates to new medicinal and cosmetic compositions comprising essential oils in combination with herbs and/or spices. The compositions may be used orally or topically.
Patent DE-69835165-T2 (DE)
Inventor: MCSHANE JAMES
IPC: A61K47/26
Filed: 1998-09-14
Granted: 2007-06-06
Abstract: The present invention provides pharmaceutical formulations suitable for intravenous injection comprising a lyophilized anti-ulcerative agent reconstituted in isotonic solutions suitable for intravenous administration, such as 5 % dextrose or 0.9 % sodium chloride. The solutions are brought to a pH of between about 9 and about 12, preferably between about pH 10 and 11, by a glycine-sodium hydroxide buffer. Such formulations are chemically and physically stable, and do not significantly change color, for at least between about 6 and about 12 hours at room temperature, and are stable to color change for from between about 24 and 48 hours if kept at 5  DEG C.
Patent DE-69902833-T2 (DE)
Inventor: KOBAYASHI SHU
IPC: B01J23/46
Filed: 1999-02-22
Granted: 2003-05-28
Abstract: The invention relates to osmium oxide compositions comprising an osmium oxide microencapsulated in an aromatic polyolefin, the method for preparation of an osmium oxide, and a method for preparing a chiral diol compound.
Patent DE-69903469-T2 (DE)
Inventor: GAO YUAN
IPC: H01M4/50
Filed: 1999-11-19
Granted: 2003-08-14
Abstract: The present invention includes lithium manganese oxide compounds of the formula:wherein 0<x<0.5, [A] is a combination of two or more dopants, and the average oxidation state N of the dopant combination [A] is +2.8<=N<=+3.2. The present invention also includes lithium and lithium-ion secondary batteries that use these lithium manganese oxide compounds as the positive electrode material. Moreover, the present invention includes methods of preparing these lithium manganese oxide compounds.
Patent DE-69903572-T2 (DE)
Inventor: KETRENOS JAMES P
IPC: G06F9/44
Filed: 1999-08-26
Granted: 2003-06-12
Abstract: Tasks associated with an add-on software program can be seamlessly incorporated into core software tasks. A directory associated with the add-on is interrogated for similar tasks when the corresponding task is actuated in the core software program. The directory names are copied over into an array associated with the core software program and a link is created between those names in the array and the directory from which they were taken. Thus, a drop-down menu may be implemented in a task or navigation bar in the core software program which allows the corresponding tasks in the add-on to be seamlessly incorporated into the operation of the core software.